Actionable Biomarkers for Rheumatoid Arthritis

3,345 views

|

January 23, 2012

  • Share
  • We have developed multiplex proteomic tests to guide therapeutic decision making in rheumatoid arthritis (RA). Through proteomic discovery, we have identified autoantibody and cytokine profiles with predictive utility for two actionable situations in RA.  First, to facilitate early diagnosis and initiation of disease-modifying therapies that alter the natural history of RA. Second, to identify patients likely to respond to anti-TNF therapeutics.

    Flow Chemistry

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.